Design Therapeutics annual net profit margin
2020
Design Therapeutics's net profit margin was −3,663.72% for fiscal 2020.
View full Design Therapeutics company overview| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | −3,663.72% | — |
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q4 2020 | 2020-12-31 | −11,681.82% | — |
| Q3 2020 | 2020-09-30 | −11,600.00% | — |
| Q2 2020 | 2020-06-30 | −4,651.61% | — |
| Q1 2020 | 2020-03-31 | −466.90% | — |
The latest reported quarter, Q4 2020, shows −11,681.82%.
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Design Therapeutics source filings ↗